Search Results

Filter
  • 1-25 of  300 results for ""Blood Glucose Self-Monitoring methods""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems.

  • Authors : Eichenlaub M; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.; Pleus S

Subjects: Blood Glucose* ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/diagnosis ; Hyperglycemia*/Hyperglycemia*/Hyperglycemia*/prevention & control

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Apr; Vol. 26 (4), pp. 263-275. Date of Electronic Publication: 2024 Feb 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Effect of Arterialization on Venous Blood Glucose Concentrations and Implications for Observed Continuous Glucose Monitoring Accuracy.

  • Authors : Pleus S; Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm, Germany.; Link M

Subjects: Blood Glucose* ; Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/methods; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Apr; Vol. 26 (4), pp. 238-245. Date of Electronic Publication: 2024 Feb 13.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.

  • Authors : Mathieu C; Department of Endocrinology, UZ Gasthuisberg, Leuven, Belgium.; Ahmed W

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Mar; Vol. 26 (S3), pp. 66-75.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Accuracy of a Continuous Glucose Monitor During Pediatric Type 1 Diabetes Inpatient Admissions.

  • Authors : Cobry EC; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Pyle L

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/complications; Adult

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Feb; Vol. 26 (2), pp. 119-124. Date of Electronic Publication: 2024 Jan 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

A Minimized Measurement Scheme for Predicting HbA1c Using Discrete Self-Monitoring Blood Glucose Data Within 4 Weeks for People with Type 2 Diabetes.

  • Authors : Li A; Department of Endocrinology, Peking University First Hospital, Beijing, China.; Li X

Subjects: Blood Glucose* ; Diabetes Mellitus, Type 2*; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Feb; Vol. 26 (2), pp. 103-111. Date of Electronic Publication: 2024 Jan 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Ultrarapid Insulin Use Can Reduce Postprandial Hyperglycemia and Late Hypoglycemia, Even in Delayed Insulin Injections: A Connected Insulin Cap-Based Real-World Study.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/chemically induced ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/prevention & control

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Jan; Vol. 26 (1), pp. 1-10. Date of Electronic Publication: 2023 Dec 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

A European Cost-Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans ; Insulin

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Dec; Vol. 25 (12), pp. 864-876.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Testing the Real-World Accuracy of the Dexcom G6 Pro CGM During the Insulin-Only Bionic Pancreas Pivotal Trial.

  • Authors : Marak MC; Jaeb Center for Health Research, Tampa, Florida, USA.; Calhoun P

Subjects: Insulin*/Insulin*/Insulin*/therapeutic use ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Nov; Vol. 25 (11), pp. 817-821. Date of Electronic Publication: 2023 Oct 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Automated Insulin Delivery with Remote Real-Time Continuous Glucose Monitoring for Hospitalized Patients with Diabetes: A Multicenter, Single-Arm, Feasibility Trial.

  • Authors : Davis GM; Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Hughes MS

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetic Ketoacidosis* ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/chemically induced

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Oct; Vol. 25 (10), pp. 677-688. Date of Electronic Publication: 2023 Aug 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time.

  • Authors : Kovatchev B; Center for Diabetes Technology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.; Lobo B

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Aug; Vol. 25 (8), pp. 519-528.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Continuous Glucose Monitoring by Insulin-Treated Pilots Flying Commercial Aircraft Within the ARA.MED.330 Diabetes Protocol: A Preliminary Feasibility Study.

  • Authors : Garden GL; Faculty of Health and Medical Sciences, University of Surrey, Guildford, United Kingdom.; Shojaee-Moradie F

Subjects: Insulin*/Insulin*/Insulin*/therapeutic use ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Male

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Aug; Vol. 25 (8), pp. 543-548.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes.

  • Authors : Donaldson LE; Department of Medicine, The University of Melbourne, Melbourne, Australia.; Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Melbourne, Australia.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/diagnosis; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Jul; Vol. 25 (7), pp. 497-506. Date of Electronic Publication: 2023 May 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE.

  • Authors : Bergenstal RM; International Diabetes Center, HealthPartners Institute, 3800 Park Nicollet Blvd, Minneapolis, Minnesota, USA.; Hachmann-Nielsen E

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/etiology

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Jun; Vol. 25 (6), pp. 378-383. Date of Electronic Publication: 2023 May 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72.

  • Authors : Beck RW; JAEB Center for Health Research, Tampa, Florida, USA.; Kanapka LG

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/prevention & control ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/drug therapy

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 May; Vol. 25 (5), pp. 329-342. Date of Electronic Publication: 2023 Apr 12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

A New Index of Insulin Sensitivity from Glucose Sensor and Insulin Pump Data: In Silico and In Vivo Validation in Youths with Type 1 Diabetes.

  • Authors : Schiavon M; Department of Information Engineering, University of Padova, Padova, Italy.; Galderisi A

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Insulin Resistance*; Adolescent

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Apr; Vol. 25 (4), pp. 270-278. Date of Electronic Publication: 2023 Feb 17.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Impact of Expanding Access to Continuous Glucose Monitoring Systems Among Insulin Users with Type 1 or Type 2 Diabetes.

  • Authors : Pathak S; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina, USA.; Kearin K

Subjects: Diabetes Mellitus, Type 2* ; Diabetes Mellitus, Type 1*; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Mar; Vol. 25 (3), pp. 169-177. Date of Electronic Publication: 2023 Jan 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

The AH-HA! Project: Transforming Group Diabetes Self-Management Education Through the Addition of Flash Glucose Monitoring.

  • Authors : Polonsky WH; Behavioral Diabetes Institute, San Diego, California, USA.; University of California, San Diego, California, USA.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/psychology ; Diabetes Mellitus, Type 2* ; Self-Management*

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Mar; Vol. 25 (3), pp. 194-200. Date of Electronic Publication: 2022 Dec 12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

A Statistical Approach for Assessing the Compliance of Integrated Continuous Glucose Monitoring Systems with Food and Drug Administration Accuracy Requirements.

Subjects: Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/methods ; Blood Glucose*; United States

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Mar; Vol. 25 (3), pp. 212-216.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Continuous Glucose Monitoring Time Series Data Analysis: A Time Series Analysis Package for Continuous Glucose Monitoring Data.

  • Authors : Shao J; Department of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.; Liu Z

Subjects: Blood Glucose*/Blood Glucose*/Blood Glucose*/analysis ; Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/Blood Glucose Self-Monitoring*/methods; Time Factors

  • Source: Journal of computational biology : a journal of computational molecular cell biology [J Comput Biol] 2023 Jan; Vol. 30 (1), pp. 112-116. Date of Electronic Publication: 2022 Aug Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9433358 Publication Model: Print-Electronic

Record details

×
Academic Journal

Software Packages and Tools for the Analysis of Continuous Glucose Monitoring Data.

  • Authors : Piersanti A; Department of Information Engineering, Università Politecnica delle Marche, Ancona, Italy.; Giurato F

Subjects: Diabetes Mellitus*/Diabetes Mellitus*/Diabetes Mellitus*/therapy ; Wearable Electronic Devices* ; Diabetes Mellitus, Type 1*

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Jan; Vol. 25 (1), pp. 69-85. Date of Electronic Publication: 2022 Nov 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

The Optimal Duration of a Run-In Period to Initiate Continuous Glucose Monitoring for a Randomized Trial.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Dec; Vol. 24 (12), pp. 868-872.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
Academic Journal

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations.

  • Authors : Forlenza GP; Barbara Davis Center, Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Denver, Denver, Colorado, USA.; Carlson AL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Nov; Vol. 24 (11), pp. 814-823. Date of Electronic Publication: 2022 Jul 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.

  • Authors : Montaser E; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.; Fabris C

Subjects: Diabetes Mellitus, Type 2* ; Hypoglycemia* ; Hyperglycemia*

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Nov; Vol. 24 (11), pp. 797-804. Date of Electronic Publication: 2022 Jul 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.

  • Authors : Lanzinger S; Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany.; German Centre for Diabetes Research (DZD), München-Neuherberg, Germany.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Oct; Vol. 24 (10), pp. 763-769. Date of Electronic Publication: 2022 Jul 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic

Record details

×
Academic Journal

The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.

  • Authors : Lynch J; Department of Pediatrics, University of Texas Health Sciences Center, San Antonio, San Antonio, Texas, USA.; Kanapka LG

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Insulin*/Insulin*/Insulin*/therapeutic use; Adolescent

  • Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Oct; Vol. 24 (10), pp. 726-736.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited

Record details

×
  • 1-25 of  300 results for ""Blood Glucose Self-Monitoring methods""